Literature DB >> 15885348

Developing concepts on MELD: delta and cutoffs.

Gennaro D'Amico.   

Abstract

Mesh:

Year:  2005        PMID: 15885348     DOI: 10.1016/j.jhep.2005.03.009

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

Review 1.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

2.  Prognostic Value of Model for End-Stage Liver Disease Score Measurements on a Daily Basis in Critically Ill Patients With Cirrhosis.

Authors:  Thoetchai Peeraphatdit; Niyada Naksuk; Charat Thongprayoon; William S Harmsen; Terry M Therneau; Paola Ricci; Lewis R Roberts; Roongruedee Chaiteerakij
Journal:  Mayo Clin Proc       Date:  2015-08-03       Impact factor: 7.616

3.  Delta model for end-stage liver disease and delta clinical prognostic indicator as predictors of mortality in patients with viral acute liver failure.

Authors:  Ashok Kumar Pannu; Ashish Bhalla; Chelapati Rao; Charanpreet Singh
Journal:  Int J Crit Illn Inj Sci       Date:  2017 Oct-Dec

4.  Plasma fetal bile acids 7α-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxachola-4,6-dien-24-oic acid indicate severity of liver cirrhosis.

Authors:  Tudor Mocan; Dong Wook Kang; Billy J Molloy; Hyeonho Jeon; Zeno A Spârchez; Diren Beyoğlu; Jeffrey R Idle
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

5.  Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.

Authors:  Guy N Brock; Kenneth Washburn; Michael R Marvin
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.